Search Within

Roisin Eilish O'Cearbhaill

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (127)
  2. Journal Article (123)
  3. Review (9)
  4. Editorial (5)
  5. Book Section (3)
  6. Guidelines (2)
Groups
  1. Department of Medicine (269)
  2. GDMT, Medicine (269)
  3. Gynecologic Medicine Service (269)
  4. Gynecology Disease Management Team (269)
  5. Hematologic Malignancies, Division of (269)
  6. Solid Tumor Oncology Division (269)

More Groups

People
  1. Carol Aghajanian (98)
  2. Alexia Iasonos (75)
  3. Qin Zhou (68)
  4. Rachel Grisham (68)
  5. Dennis Chi (67)
  6. William Tew (66)

More People

Years
  1. 2025 (11)
  2. 2024 (30)
  3. 2023 (43)
  4. 2022 (31)
  5. 2021 (25)
  6. 2020 (41)

More Years

Publications
  1. Gynecologic Oncology (91)
  2. Journal of Clinical Oncology (45)
  3. International Journal of Gynecological Cancer (39)
  4. Annals of Oncology (13)
  5. Gynecologic Oncology Reports (11)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. Elsevier Inc. (98)
  2. American Society of Clinical Oncology (48)
  3. Lippincott Williams & Wilkins (40)
  4. Oxford University Press (13)
  5. American Association for Cancer Research (12)
  6. Elsevier B.V. (11)

More Publishers

Results (269)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
    Meeting Abstract

    Hong, D. S.; SciMentum, S. L.; Tanyi, J.; MacMullen, L.; Jalbert, L.; Muzithras, V. P.; Zikaras, K.; Cao, L.; O'Cearbhaill, R. E.; Quintás-Cardama, A.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
    Meeting Abstract

    Vergote, I. B.; Monk, B. J.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; Collins, D. C.; Mirza, M. R.; O'Malley, D.; Gennigens, C.; Pignata, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Quaternary and beyond cytoreduction: An updated and expanded analysis
    Journal Article

    Manning-Geist, B. L.; Chi, D. S.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; O'Cearbhaill, R. E.; Abu-Rustum, N. R.; Leitao, M. M. Jr
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
    Journal Article

    Kyi, C.; Doubrovina, E.; Zhou, Q.; Kravetz, S.; Iasonos, A.; Aghajanian, C.; Sabbatini, P.; Spriggs, D.; O'Reilly, R. J.; O'Cearbhaill, R. E.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • 10-year survival in patients diagnosed with high-grade epithelial ovarian cancer: A new metric for a new millennium
    Meeting Abstract

    Filippova, O.; Straubhar, A.; Lugo Santiago, N.; Zivanovic, O.; Gardner, G.; Tew, W.; O'Cearbhaill, R.; Grisham, R.; Sonoda, Y.; Roche, K. L.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer
    Meeting Abstract

    Lim, S.; Moss, H.; Havrilesky, L.; O'Cearbhaill, R.; Abu-Rustum, N.; Liang, M.; Wright, J.; Aviki, E.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
    Meeting Abstract

    O'Cearbhaill, R.; Pérez-Fidalgo, J. A.; Monk, B.; Tusquets, I.; McCormick, C.; Fuentes, J.; Moore, R.; Vulsteke, C.; Shahin, M.; Forget, F.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis
    Meeting Abstract

    Lara, O.; Smith, M.; Wang, Y.; O'Cearbhaill, R.; Blank, S.; Kolev, V.; Carr, C.; Knisely, A.; McEachron, J.; Gabor, L.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save